Artiva Biotherapeutics, Inc. (ARTV) Capital expenditures 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.6MFY2025 · since FY2023: $3.3M → $2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.6M | +303.0% |
| FY2024 | $642,000 | -80.3% |
| FY2023 | $3.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice